Futura Medical plc (FAMDF)

Market Cap	3.86M -89.5%
Revenue (ttm)	2.28M -87.8%
Net Income	-12.21M
EPS	-0.04
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	7,000
Open	0.0070
Previous Close	0.01495
Day's Range	0.0070 - 0.0070
52-Week Range	0.0013 - 0.2000
Beta	0.02
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 11, 2026

About Futura Medical

Futura Medical plc research, develops, and commercializes pharmaceutical and healthcare products for sexual health. The company’s lead product includes Eroxon, a topical treatment for erectile dysfunction. It also develops WSD4000 for the treatment of sexual dysfunction in women. The company operates in the United Kingdom, the European Union, the United States, and internationally. Futura Medical plc was incorporated in 2001 and is headquartered in Guildford, the United Kingdom.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2001
• Employees: 13
• Stock Exchange: OTCMKTS
• Ticker Symbol: FAMDF

Financial Performance

Financial numbers in GBP

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Jun 28, 2026

Data Sources Report a data error